The Law Offices of Frank R. Cruz Continues Investigation of Athira Pharma, Inc. (ATHA) on Behalf of InvestorsBusiness Wire • 06/23/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athira Pharma (ATHA) Investors to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law ViolationsPRNewsWire • 06/23/21
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Athira Pharma, Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 06/23/21
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Athira Pharma, Inc. (ATHA) on Behalf of InvestorsBusiness Wire • 06/22/21
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Athira Pharma, Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 06/22/21
ATHIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Athira Pharma, Inc. on Behalf of Athira Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 06/22/21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Athira Pharma, Inc. (ATHA) on Behalf of InvestorsBusiness Wire • 06/21/21
The Law Offices of Frank R. Cruz Announces Investigation of Athira Pharma, Inc. (ATHA) on Behalf of InvestorsBusiness Wire • 06/21/21
Implied Volatility Surging for Athira Pharma (ATHA) Stock OptionsZacks Investment Research • 06/21/21
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Athira Pharma, Inc. and Encourages Investors with Losses to Contact the FirmBusiness Wire • 06/18/21
Wolf Popper LLP Announces Investigation on Behalf of Purchasers of Athira Pharma, Inc. (ATHA) Common StockNewsfile Corp • 06/18/21
Berman Tabacco Investigates Potential Securities Claims Against Athira Pharma, Inc. (ATHA)Newsfile Corp • 06/18/21
Athira Pharma Chief Operating Officer, Mark Litton, Assumes Day-to-Day Leadership Responsibilities of CompanyGlobeNewsWire • 06/17/21
Approval of Biogen's drug for Alzheimer's disease may ease path for others such as Athira PharmaGeekWire • 06/07/21
Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business HighlightsGlobeNewsWire • 05/13/21
Athira Pharma, Inc. (ATHA) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 04/22/21
Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation ForumGlobeNewsWire • 04/21/21
Athira Pharma to Host Educational Webinar on Targeting HGF/MET: A Naturally Occurring Neuronal Repair PathwayGlobeNewsWire • 04/08/21